Longhorn Vaccines & Diagnostics' PrimeStore® MTM Validated with New Data for Large-Scale, Global TB Screening

Written By Van Agens
Van Agens
Previous

Longhorn Vaccines and Diagnostics Presents New Preclinical Data on Broad-Spectrum Anti-Bacterial Monoclonal Antibody LHNVD-501
Next

Longhorn Vaccines and Diagnostics to Present Late-Breaking Poster at ESCMID 2025 on LHNVD-303 to Treat and Prevent Antimicrobial Resistance